XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2017
Stockholders' Equity [Abstract] |
Stockholders' Equity | NOTE 8. STOCKHOLDERS’ E QUITY Equity Offering During the three-month period ended March 31, 2016, we issued 3.1 million shares of our common stock at an average price of $8.80 per share through our “at-the-market” offering, resulting in net proceeds of $26.5 million. During the three-month period ended March 31, 2017 we did not issue any shares pursuant to our “at-the-market” offering program; however, in February 2017, we filed an additional prospectus supplement pursuant to which we may offer and sell, from time to time, additional shares of our common stock having an aggregate offering price of up to $60.0 million. We pay a commission equal to 3% of the gross proceeds from the sale of shares of our common stock under the sales agreement. We are not obligated to sell shares of our common stock under the sales agreement. Subject to certain exceptions set forth in our existing Facility Agreement, holders of our Notes may elect to receive 25% of the net proceeds from financing activities that include an equity component as prepayment of the Notes to be applied first, to accrued and unpaid interest and second, to principal. However, in April 2017 holders representing a majority of the aggregate principal amount of the outstanding Notes waived such right in connection with the issuance and sale of shares of common stock under our current “at-the-market” offering. Warrants In connection with the execution of the Facility Agreement, we issued immediately exercisable warrants to purchase 5.5 million shares of common stock at an exercise price per share initially equal to $2.63, all of which were outstanding at December 31, 2015. The number of shares of common stock into which the warrants are exercisable and the exercise price will be adjusted to reflect any stock splits, payment of stock dividends, recapitalizations, reclassifications or other similar adjustments in the number of outstanding shares of common stock. The exercise price may also be adjusted to reflect certain dividends or other distributions, including distributions of stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or similar transaction. During the three-month periods ended March 31, 2016, warrants to purchase 3,818,000 shares of common stock were net exercised, resulting in the issuance of approximately 3.0 million shares with all warrants being fully net exercised by December 31, 2016. As of March 31, 2017, no warrants remained outstanding. Equity Plans As of March 31, 2017, we had three active equity compensation plans: the 2010 Equity Incentive Plan, the 2010 Outside Director Equity Incentive Plan, and the 2010 Employee Stock Purchase Plan (“ESPP”). The following table summarizes stock option activity for all our stock option plans for the three-month period ended March 31, 2017 (in thousands, except per share amounts): ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  | Stock Options Outstanding
﻿ |  |  |  |  |  |  |  | Weighted
﻿ | Shares available |  | Number |  |  |  |  | average
﻿ | for grant |  | of shares |  | Exercise price |  | exercise price
﻿Balances, December 31, 2016 | 6,835 |  | 22,501 |  | $ | 1.16 – 16.00 |  | $ | 6.30
﻿Additional shares reserved | 4,634 |  |  |  |  |  |  |  |
﻿Options granted | (4,708) |  | 4,708 |  |  | 4.78 – 5.27 |  |  | 5.26
﻿Options exercised | — |  | (114) |  |  | 1.16 – 4.55 |  |  | 2.70
﻿Options canceled | 439 |  | (439) |  |  | 1.16 – 11.64 |  |  | 7.34
﻿Balances, March 31, 2017 | 7,200 |  | 26,656 |  | $ | 1.16 – 16.00 |  | $ | 6.11
﻿ Shares issued under our ESPP totaled 750,005 and 668,566 shares during the three-month periods ended March 31, 2017 and 2016, respectively. As of March 31, 2017, 1,841,595 shares of our common stock remain available for issuance under our ESPP. Stock-Based Compensation Total stock-based compensation expense consists of the following (in thousands): ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ | Three-Month Periods Ended March 31, |  |  |
﻿ | 2017 |  | 2016 |  |  |  |  |
﻿Cost of revenue | $ | 523 |  | $ | 499 |  |  |  |  |  |  |
﻿Research and development |  | 2,030 |  |  | 1,910 |  |  |  |  |  |  |
﻿Sales, general and administrative |  | 2,431 |  |  | 2,172 |  |  |  |  |  |  |
﻿Total stock-based compensation expense | $ | 4,984 |  | $ | 4,581 |  |  |  |  |  |  |
﻿ W e estimated the fair value of employee stock options on the grant date using the Black-Scholes option pricing model. The estimated fair value of employee stock options is amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the following weighted average assumptions: ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ | Three-Month Periods Ended March 31, |  |  |  |
﻿Stock Option | 2017 |  | 2016 |  |  |  |  |  |
﻿Expected term in years | 6.1 |  | 6.1 |  |  |  |  |  |
﻿Expected volatility | 70% |  | 70% |  |  |  |  |  |
﻿Risk-free interest rate | 2.1% |  | 1.5% |  |  |  |  |  |
﻿Dividend yield | — |  | — |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
We estimate the value of employee stock purchase rights on the grant date using the Black-Scholes option pricing model. The fair value of shares to be purchased under our ESPP was estimated using the following assumptions: ﻿
﻿ |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |
﻿ | Three-Month Periods Ended March 31, |  |  |
﻿ESPP | 2017 |  | 2016 |  |  |  |  |
﻿Expected term in years | 0.5-2.0 |  | 0.5-2.0 |  |  |  |  |
﻿Expected volatility | 70% |  | 70% |  |  |  |  |
﻿Risk-free interest rate | 0.8%-1.3% |  | 0.5%-0.9% |  |  |  |  |
﻿Dividend yield | — |  | — |  |  |  |  |
﻿ ﻿ ﻿ ﻿

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration